← Oncology Approval Tracker

FDA DECISION ·

Beizray

docetaxel · Zhuhai Beihai Biotech

FDA approvalNew formulationMultiple solid tumors
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Docetaxel injection for labeled settings in breast cancer, non-small cell lung cancer, metastatic castration-resistant prostate cancer, gastric adenocarcinoma and locally advanced head and neck squamous cell carcinoma.

LAMPGEN ANALYSIS

Why it matters

The albumin-containing formulation is a distinct docetaxel presentation for established oncology uses.

What research teams should watch

Maintain separate preparation instructions and verify infusion concentration, corticosteroid premedication and regimen before dispensing.

PRIMARY RECORDS

Sources